Uffe Birk Jensen - Genetic Mutations

Author Information

Uffe Birk Jensen is affiliated with the Department of Clinical Genetics at Aarhus University Hospital, located at Brendstrupgaardsvej 21C, 8200 Aarhus N, Denmark. His research spans across various areas in genetics, with a focus on genetic risk factors for cancer and other genetic disorders.

Research Contributions

Uffe Birk Jensen has made significant contributions to genetics research, particularly in understanding genetic modifiers of cancer risk, neurodevelopmental disorders, and the application of CRISPR/Cas9 technology. His recent works include studies on breast cancer risk for BRCA1/BRCA2 mutation carriers, the genetic basis of Charcot-Marie-Tooth disease, and variations in colorectal cancer risk in Lynch syndrome families. His research has implications for personalized medicine and genetic risk prediction.

Aliases

Uffe Birk Jensen is also known by several aliases, including U B Jensen, Uffe Jensen, Uffe B Jensen, Uffe B. Jensen, and U. B. Jensen.

Publication and Citation Metrics

Metric	Value
Total Citations	8198
H-Index	50
Paper Count	182

Publications:

A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers

DOI: 10.1038/s41467-020-20496-3

Year: 2021

A Search for Undiagnosed Charcot-Marie-Tooth Disease Among Patients Registered with Unspecified Polyneuropathy in the Danish National Patient Registry

DOI: 10.2147/CLEP.S292676

Year: 2021

Breast and Prostate Cancer Risks for Male BRCA1 and BRCA2 Pathogenic Variant Carriers Using Polygenic Risk Scores

DOI: 10.1093/jnci/djab147

Year: 2021

Mono‐allelic loss of YTHDF3 and neurodevelopmental disorder: clinical features of four individuals with 8q12.3 deletions

DOI: 10.1111/cge.14083

Year: 2021

Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers

DOI: 10.1038/s41467-021-23162-4

Year: 2021

The CRISPR/Cas9 Minipig—A Transgenic Minipig to Produce Specific Mutations in Designated Tissues

DOI: 10.3390/cancers13123024

Year: 2021

Variation in the risk of colorectal cancer in families with Lynch syndrome: a retrospective cohort study.

DOI: 10.1016/S1470-2045(21)00189-3

Year: 2021

The predictive ability of the 313 variant–based polygenic risk score for contralateral breast cancer risk prediction in women of European ancestry with a heterozygous BRCA1 or BRCA2 pathogenic variant

DOI: 10.1038/s41436-021-01198-7

Year: 2021

The role of stem cell antigen-1/Lymphocyte antigen 6A-2/6E-1 knock out in murine epidermis.

DOI: 10.1016/j.scr.2020.102047

Year: 2020

Deleterious mis‐splicing of STK11 caused by a novel single‐nucleotide substitution in the 3′ polypyrimidine tract of intron five

DOI: 10.1002/mgg3.1381

Year: 2020

How Does Genetic Testing Inform Cancer Treatment?

What Are the Implications of Genetic Research on ASD?

What Are the Advantages of Third Generation Sequencing Over Previous Methods?

How Do Genetic Mutations Affect Fertility?

How Does PacBio's SMRT Technology Work?

What Are Chromosomal Mutations?

What are Biological Agents that Induce Mutations?

How do TALENs work?

How Reliable Are Prenatal Screening Tests?

Is Genetic Counseling Recommended?

Partnered Content Networks

Relevant Topics